Show
Sort by
-
Dupilumab improves asthma control as assessed by total and individual item scores of the 6-item asthma control questionnaire in patients with severe chronic rhinosinusitis with nasal polyps and comorbid asthma : pooled results from the SINUS-24 and SINUS-52 phase 3 studies
-
Baseline-Charakteristika von Patienten mit chronischer Rhinosinusitis mit nasalen Polypen (mit und ohne Asthma) in SINUS-52 : einer randomisierten, doppel-blinden, Phase-3-Studie von Dupilumab
-
Dupilumab improves health-related quality of life in patients with oral corticosteroid-dependent, severe asthma with comorbid chronic rhinosinusitis with and without nasal polyps
-
Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps (with and without asthma) enrolled in SINUS-52 : a randomized, double-blind, phase 3 study of dupilumab
-
Dupilumab improved asthma control and health-related quality of life in patients with oral-corticosteroid-dependent severe asthma in the phase 3 LIBERTY ASTHMA VENTURE study
-
Dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyposis : pooled results from the SINUS-24 and SINUS-52 phase 3 studies
-
Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS- 24, SINUS- 52 phase 3 studies
-
Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course
-
Dupilumab reduces percentage volume of sinuses occupied by disease in patients with CRSwNP
-
Dupilumab produces rapid and sustained improvements in asthma-related symptoms in patients with uncontrolled, moderate-to-severe asthma from the LIBERTY ASTHMA QUEST study